Report cover image

Global DNA & RNA Oligonucleotides Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 100 Pages
SKU # APRC20354389

Description

Summary

According to APO Research, The global DNA & RNA Oligonucleotides market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of DNA & RNA Oligonucleotides include Berry Genomics, BGI, Brooks Life Sciences, Dna Link, Eurofins Scientific, Genotypic Technology, Illumina, LabCorp and Macrogen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA & RNA Oligonucleotides.

The DNA & RNA Oligonucleotides market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA & RNA Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

DNA & RNA Oligonucleotides Segment by Company

Berry Genomics
BGI
Brooks Life Sciences
Dna Link
Eurofins Scientific
Genotypic Technology
Illumina
LabCorp
Macrogen
Natera
Roche

DNA & RNA Oligonucleotides Segment by Type

DNA Oligonucleotides
RNA Oligonucleotides

DNA & RNA Oligonucleotides Segment by Application

Biopharma Companies
Academic & Research Organizations
Hospitals and Clinics
Others

DNA & RNA Oligonucleotides Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA & RNA Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA & RNA Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA & RNA Oligonucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of DNA & RNA Oligonucleotides companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Table of Contents

100 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global DNA & RNA Oligonucleotides Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global DNA & RNA Oligonucleotides Market Size by Region (2020-2031)
1.4.1 Global DNA & RNA Oligonucleotides Market Size by Region (2020-2025)
1.4.2 Global DNA & RNA Oligonucleotides Market Size by Region (2026-2031)
1.5 Key Regions DNA & RNA Oligonucleotides Market Size (2020-2031)
1.5.1 North America DNA & RNA Oligonucleotides Market Size Growth Rate (2020-2031)
1.5.2 Europe DNA & RNA Oligonucleotides Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size Growth Rate (2020-2031)
1.5.4 South America DNA & RNA Oligonucleotides Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa DNA & RNA Oligonucleotides Market Size Growth Rate (2020-2031)
2 DNA & RNA Oligonucleotides Market by Type
2.1 Type Introduction
2.1.1 DNA Oligonucleotides
2.1.2 RNA Oligonucleotides
2.2 Global DNA & RNA Oligonucleotides Market Size by Type
2.2.1 Global DNA & RNA Oligonucleotides Market Size Overview by Type (2020-2031)
2.2.2 Global DNA & RNA Oligonucleotides Historic Market Size Review by Type (2020-2025)
2.2.3 Global DNA & RNA Oligonucleotides Market Size Forecasted by Type (2026-2031)
2.3 Global DNA & RNA Oligonucleotides Market Size by Regions
2.3.1 North America DNA & RNA Oligonucleotides Market Size Breakdown by Type (2020-2025)
2.3.2 Europe DNA & RNA Oligonucleotides Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size Breakdown by Type (2020-2025)
2.3.4 South America DNA & RNA Oligonucleotides Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa DNA & RNA Oligonucleotides Market Size Breakdown by Type (2020-2025)
3 DNA & RNA Oligonucleotides Market by Application
3.1 Type Introduction
3.1.1 Biopharma Companies
3.1.2 Academic & Research Organizations
3.1.3 Hospitals and Clinics
3.1.4 Others
3.2 Global DNA & RNA Oligonucleotides Market Size by Application
3.2.1 Global DNA & RNA Oligonucleotides Market Size Overview by Application (2020-2031)
3.2.2 Global DNA & RNA Oligonucleotides Historic Market Size Review by Application (2020-2025)
3.2.3 Global DNA & RNA Oligonucleotides Market Size Forecasted by Application (2026-2031)
3.3 Global DNA & RNA Oligonucleotides Market Size by Regions
3.3.1 North America DNA & RNA Oligonucleotides Market Size Breakdown by Application (2020-2025)
3.3.2 Europe DNA & RNA Oligonucleotides Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size Breakdown by Application (2020-2025)
3.3.4 South America DNA & RNA Oligonucleotides Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa DNA & RNA Oligonucleotides Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 DNA & RNA Oligonucleotides Industry Trends
4.2 DNA & RNA Oligonucleotides Industry Drivers
4.3 DNA & RNA Oligonucleotides Industry Opportunities and Challenges
4.4 DNA & RNA Oligonucleotides Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by DNA & RNA Oligonucleotides Revenue (2020-2025)
5.2 Global DNA & RNA Oligonucleotides Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global DNA & RNA Oligonucleotides Key Company Headquarters & Area Served
5.4 Global DNA & RNA Oligonucleotides Company, Product Type & Application
5.5 Global DNA & RNA Oligonucleotides Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global DNA & RNA Oligonucleotides Market CR5 and HHI
5.6.2 Global Top 5 and 10 DNA & RNA Oligonucleotides Players Market Share by Revenue in 2024
5.6.3 2024 DNA & RNA Oligonucleotides Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Berry Genomics
6.1.1 Berry Genomics Comapny Information
6.1.2 Berry Genomics Business Overview
6.1.3 Berry Genomics DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Berry Genomics DNA & RNA Oligonucleotides Product Portfolio
6.1.5 Berry Genomics Recent Developments
6.2 BGI
6.2.1 BGI Comapny Information
6.2.2 BGI Business Overview
6.2.3 BGI DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 BGI DNA & RNA Oligonucleotides Product Portfolio
6.2.5 BGI Recent Developments
6.3 Brooks Life Sciences
6.3.1 Brooks Life Sciences Comapny Information
6.3.2 Brooks Life Sciences Business Overview
6.3.3 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Brooks Life Sciences DNA & RNA Oligonucleotides Product Portfolio
6.3.5 Brooks Life Sciences Recent Developments
6.4 Dna Link
6.4.1 Dna Link Comapny Information
6.4.2 Dna Link Business Overview
6.4.3 Dna Link DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Dna Link DNA & RNA Oligonucleotides Product Portfolio
6.4.5 Dna Link Recent Developments
6.5 Eurofins Scientific
6.5.1 Eurofins Scientific Comapny Information
6.5.2 Eurofins Scientific Business Overview
6.5.3 Eurofins Scientific DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Eurofins Scientific DNA & RNA Oligonucleotides Product Portfolio
6.5.5 Eurofins Scientific Recent Developments
6.6 Genotypic Technology
6.6.1 Genotypic Technology Comapny Information
6.6.2 Genotypic Technology Business Overview
6.6.3 Genotypic Technology DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Genotypic Technology DNA & RNA Oligonucleotides Product Portfolio
6.6.5 Genotypic Technology Recent Developments
6.7 Illumina
6.7.1 Illumina Comapny Information
6.7.2 Illumina Business Overview
6.7.3 Illumina DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Illumina DNA & RNA Oligonucleotides Product Portfolio
6.7.5 Illumina Recent Developments
6.8 LabCorp
6.8.1 LabCorp Comapny Information
6.8.2 LabCorp Business Overview
6.8.3 LabCorp DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 LabCorp DNA & RNA Oligonucleotides Product Portfolio
6.8.5 LabCorp Recent Developments
6.9 Macrogen
6.9.1 Macrogen Comapny Information
6.9.2 Macrogen Business Overview
6.9.3 Macrogen DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Macrogen DNA & RNA Oligonucleotides Product Portfolio
6.9.5 Macrogen Recent Developments
6.10 Natera
6.10.1 Natera Comapny Information
6.10.2 Natera Business Overview
6.10.3 Natera DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Natera DNA & RNA Oligonucleotides Product Portfolio
6.10.5 Natera Recent Developments
6.11 Roche
6.11.1 Roche Comapny Information
6.11.2 Roche Business Overview
6.11.3 Roche DNA & RNA Oligonucleotides Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Roche DNA & RNA Oligonucleotides Product Portfolio
6.11.5 Roche Recent Developments
7 North America
7.1 North America DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
7.3 North America DNA & RNA Oligonucleotides Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
8.3 Europe DNA & RNA Oligonucleotides Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
9.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
10.3 South America DNA & RNA Oligonucleotides Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
11.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.